Lindsay Wright

Statistics

Publications

Citations

248

H-Index

Active since

2007

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (India)

AstraZeneca (United States)

AstraZeneca (France)

Lindsay Wright is an author at AstraZeneca (United Kingdom) specializing in pharmacology, tuberculosis pharmacotherapy, and small molecule tyrosine kinase inhibitors.

Publications per year

2007–2014

Publications

Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis

V. Balasubramanian, Suresh Solapure, Harini Iyer et al. · Antimicrobial Agents and Chemotherapy · 2013 · 91 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation

Yulia Y. Tyurina, Vladimir A. Tyurin, A. Murat Kaynar et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2010 · 79 citations

Life Sciences, Biochemistry, Toxicology +17

Dual Orientation of the Outer Membrane Lipoprotein P6 of Nontypeable Haemophilus influenzae

Lea Michel, James W. Snyder, Rachel Schmidt et al. · Journal of Bacteriology · 2013 · 30 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

Peter Ballard, Bernard Barlaam, Robert H. Bradbury et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Pharmacokinetic and Pharmacodynamic Evaluation of AZD5847 in a Mouse Model of Tuberculosis

V. Balasubramanian, Suresh Solapure, Radha Krishan Shandil et al. · Antimicrobial Agents and Chemotherapy · 2014 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 6